Atlas Trials

Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity

Clinical trial NCT04221256 · WITHDRAWN

Trial details

NCT number
NCT04221256
Sponsor
Burke Medical Research Institute
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Stroke, Ischemic
Start date
2020-03-11
Primary completion
2021-02-09
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.